Celldex Therapeutics, Inc. (CLDX) Earnings Call Transcripts

20 earnings calls from June 2020 to July 21, 2026

NasdaqCM US Health Care Biotechnology

About Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. (CLDX) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 20 calls on record spanning June 18, 2020 to July 21, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 20 Celldex Therapeutics, Inc. earnings call transcripts on record, spanning June 18, 2020 to July 21, 2026. Based on this history, Celldex Therapeutics, Inc. reports semi-annually. The most recent call on file is dated July 21, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
CLDX
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
20
First call
June 18, 2020
Most recent
July 21, 2026
Reporting cadence
semi-annually
Quarter Date
Special Calls Jul 21, 2026 Read transcript
Company Conference Presentations Mar 10, 2026 Read transcript
Company Conference Presentations Mar 4, 2026 Read transcript
Company Conference Presentations Sep 9, 2025 Read transcript
Special Calls Aug 19, 2025 Read transcript
Special Calls Jun 12, 2025 Read transcript
Special Calls Oct 28, 2024 Read transcript
Special Calls Sep 25, 2024 Read transcript
Special Calls Jul 29, 2024 Read transcript
Special Calls Feb 25, 2024 Read transcript
Special Calls Nov 6, 2023 Read transcript
Special Calls Feb 26, 2023 Read transcript
Special Calls Dec 6, 2022 Read transcript
Special Calls Jun 30, 2022 Read transcript
Q4 FY2021 Feb 28, 2022 Read transcript
Company Conference Presentations Feb 16, 2022 Read transcript
Special Calls Jul 12, 2021 Read transcript
Special Calls Mar 29, 2021 Read transcript
Q2 FY2020 Aug 6, 2020 Read transcript
Shareholder/Analyst Calls Jun 18, 2020 Read transcript